SKLB1028
Showing 1 - 9 of 9
Newly Diagnosed Acute Myeloid Leukemia (AML) Trial in Chengdu (SKLB1028 Dose Escalation)
Recruiting
- Newly Diagnosed Acute Myeloid Leukemia (AML)
- SKLB1028 Dose Escalation
-
Chengdu, ChinaWest China Hospital of Sichuan University
Jun 30, 2022
Healthy Male Subjects Trial in Shanghai ([14C] SKLB1028)
Completed
- Healthy Male Subjects
- [14C] SKLB1028
-
Shanghai, Shanghai, ChinaShanghai Xuhui Central Hospital
May 6, 2022
Healthy Subjects Trial in Beijing (SKLB1028)
Completed
- Healthy Subjects
- SKLB1028
-
Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Nov 10, 2021
Advanced Solid Tumors Trial in Zhengzhou (SKLB1028)
Not yet recruiting
- Advanced Solid Tumors
- SKLB1028
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
Oct 8, 2021
Healthy Subjects Trial in Beijing (SKLB1028, Midazolam)
Completed
- Healthy Subjects
- SKLB1028
- Midazolam
-
Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Sep 26, 2021
Healthy Subjects Trial in Beijing (SKLB1028, Itraconazole, Gemfibrozil)
Active, not recruiting
- Healthy Subjects
- SKLB1028
- +3 more
-
Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Sep 26, 2021
Acute Myeloid Leukemia (AML) Trial in Chengdu (SKLB1028, Salvage Chemotherapy)
Recruiting
- Acute Myeloid Leukemia (AML)
- SKLB1028
- Salvage Chemotherapy
-
Chengdu, Sichuan, ChinaWest China hospital of Sichuan University
Nov 1, 2021
Acute Myeloid Leukemia Trial in Chengdu (SKLB1028 150mg bid, SKLB1028 200mg bid, SKLB1028 300mg qd)
Unknown status
- Acute Myeloid Leukemia
- SKLB1028 150mg bid
- +2 more
-
Chengdu, Sichuan, ChinaWest China Hospital,Sichuan University
Jul 12, 2019
Acute Myeloid Leukemia Trial in Chengdu (SKLB1028)
Unknown status
- Acute Myeloid Leukemia
- SKLB1028
-
Chengdu, Sichuan, ChinaWest China Hospital,Sichuan University
Aug 4, 2016